Anna Azvolinsky, PhD | Authors


Androgen-Targeting Therapies Increasing in CRPC

May 01, 2014

A new generation of agents that target androgen synthesis and AR signaling have provided proof of concept and robust data to support the hypothesis that the androgen pathway remains an important factor throughout the treatment of CRPC.

Approaches to Sequencing in Melanoma: Three Melanoma Specialists Weigh In

April 16, 2014

Melanoma experts and researchers have gained ground in the development of novel and effective immunotherapies as well as targeted agents for those patients with metastatic melanoma who harbor specific tumor mutations.